Literature DB >> 28066685

Linoleic Acid is a Diabetes-relevant Stimulator of Retinal Inflammation in Human Retinal Muller Cells and Microvascular Endothelial Cells.

Megan E Capozzi1, Gary W McCollum1, David B Cousins1, John S Penn1.   

Abstract

OBJECTIVE: To determine the effect of oleic acid and linoleic acid on the production and secretion of specific diabetic retinopathy- (DR-) related cytokines: vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and interleukin-8 (IL-8) by human retinal glial cells, retinal endothelial cells, and retinal pigment epithelial cells. These expression profiles will be compared to those obtained by treatment of the same cell types with elevated D-glucose, a diabetes-relevant stimulus often used in retinal cell culture experiments.
METHODS: Primary cultures of human retinal Müller cells, astrocytes, and microvascular endothelial cells (RMEC) and a human retinal pigment epithelial cell line (ARPE-19) were treated with oleic acid, linoleic acid, elevated D-glucose, or L-glucose as an osmotic control. VEGF, IL-6, and IL-8 concentrations in conditioned media were determined by colorimetric ELISA and normalized to total cellular protein.
RESULTS: In the conditioned medium of human Müller cells, linoleic and oleic acid increased VEGF production by 6.4-fold and 9.9-fold, respectively. Linoleic acid also significantly increased IL-6 by 2.9-fold and IL-8 by 5.7-fold. L-glucose and D-glucose both increased VEGF by 3.1-fold in Müller cell conditioned medium. Linoleic acid increased IL-8 concentrations by 56% in human RMEC conditioned medium. Human retinal astrocytes and ARPE-19 were unaffected by all stimuli.
CONCLUSIONS: Linoleic and oleic acid induce inflammatory mediators believed to be involved in the pathogenesis of diabetic retinopathy (DR). In culture, the free fatty acid insults, particularly linoleic acid, significantly increased cytokine production by Müller cells. In summary, these data identified Müller cells as the primary producer of these inflammatory mediators when treated with unsaturated fatty acids. This study also demonstrates that elevated glucose is an inadequate stimulus for assessing the production of inflammatory mediators. Therefore this study provides a novel in vitro model system of the dyslipidemia-induced inflammation occurring in DR.

Entities:  

Keywords:  Diabetic retinopathy; Interleukin-6; Interleukin-8; Linoleic acid; Oleic acid; Vascular endothelial growth factor

Year:  2016        PMID: 28066685      PMCID: PMC5215739          DOI: 10.4172/2155-6156.1000718

Source DB:  PubMed          Journal:  J Diabetes Metab


  12 in total

Review 1.  Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver.

Authors:  Guenther Boden
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

2.  Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model.

Authors:  R Natarajan; R G Gerrity; J-L Gu; L Lanting; L Thomas; J L Nadler
Journal:  Diabetologia       Date:  2002-01       Impact factor: 10.122

3.  Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).

Authors:  S E Baldeweg; A Golay; A Natali; B Balkau; S Del Prato; S W Coppack
Journal:  Eur J Clin Invest       Date:  2000-01       Impact factor: 4.686

4.  Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.

Authors:  Yukihiko Suzuki; Mitsuru Nakazawa; Kaori Suzuki; Hitoshi Yamazaki; Yasuhiro Miyagawa
Journal:  Jpn J Ophthalmol       Date:  2011-05-03       Impact factor: 2.447

5.  Low contribution of n-3 polyunsaturated fatty acids to plasma and erythrocyte membrane lipids in diabetic young adults.

Authors:  T Decsi; E Szabó; I Burus; T Marosvölgyi; A Kozári; E Erhardt; Gy Soltész
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-02-23       Impact factor: 4.006

6.  Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.

Authors:  Gary F Lewis; André Carpentier; Khosrow Adeli; Adria Giacca
Journal:  Endocr Rev       Date:  2002-04       Impact factor: 19.871

Review 7.  Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.

Authors:  A D Wright; P M Dodson
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

8.  Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells.

Authors:  Weiqin Chen; Donald B Jump; Maria B Grant; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  Examining the role of lipid mediators in diabetic retinopathy.

Authors:  Julia V Busik; Walter J Esselman; Gavin E Reid
Journal:  Clin Lipidol       Date:  2012-12-01

10.  Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.

Authors:  Maria Tikhonenko; Todd A Lydic; Yun Wang; Weiqin Chen; Madalina Opreanu; Andrew Sochacki; Kelly M McSorley; Rebecca L Renis; Timothy Kern; Donald B Jump; Gavin E Reid; Julia V Busik
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more
  12 in total

Review 1.  Diabetic retinopathy: Breaking the barrier.

Authors:  Randa S Eshaq; Alaa M Z Aldalati; J Steven Alexander; Norman R Harris
Journal:  Pathophysiology       Date:  2017-07-12

Review 2.  Regulations of Retinal Inflammation: Focusing on Müller Glia.

Authors:  Yingying Chen; Qinghong Xia; Yue Zeng; Yun Zhang; Meixia Zhang
Journal:  Front Cell Dev Biol       Date:  2022-04-27

Review 3.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

4.  The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

Authors:  Megan E Capozzi; Sara R Savage; Gary W McCollum; Sandra S Hammer; Carla J Ramos; Rong Yang; Colin A Bretz; John S Penn
Journal:  Exp Eye Res       Date:  2019-11-20       Impact factor: 3.467

Review 5.  The innate immune system in diabetic retinopathy.

Authors:  Warren W Pan; Feng Lin; Patrice E Fort
Journal:  Prog Retin Eye Res       Date:  2021-01-08       Impact factor: 19.704

6.  Retinal Protein O-GlcNAcylation and the Ocular Renin-angiotensin System: Signaling Cross-roads in Diabetic Retinopathy.

Authors:  Sadie K Dierschke; Michael D Dennis
Journal:  Curr Diabetes Rev       Date:  2022

7.  Palmitic Acid Induces Müller Cell Inflammation that is Potentiated by Co-treatment with Glucose.

Authors:  Megan E Capozzi; Meredith J Giblin; John S Penn
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

Review 8.  The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy.

Authors:  Josy Augustine; Evan P Troendle; Peter Barabas; Corey A McAleese; Thomas Friedel; Alan W Stitt; Tim M Curtis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

9.  Nuclear factor of activated T-cells (NFAT) regulation of IL-1β-induced retinal vascular inflammation.

Authors:  Meredith J Giblin; Taylor E Smith; Garrett Winkler; Hannah A Pendergrass; Minjae J Kim; Megan E Capozzi; Rong Yang; Gary W McCollum; John S Penn
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-07-31       Impact factor: 5.187

10.  Reproducing diabetic retinopathy features using newly developed human induced-pluripotent stem cell-derived retinal Müller glial cells.

Authors:  Aude Couturier; Guillaume Blot; Lucile Vignaud; Céline Nanteau; Amélie Slembrouck-Brec; Valérie Fradot; Niyazi Acar; José-Alain Sahel; Ramin Tadayoni; Gilles Thuret; Florian Sennlaub; Jerome E Roger; Olivier Goureau; Xavier Guillonneau; Sacha Reichman
Journal:  Glia       Date:  2021-03-08       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.